Innate Pharma S.A.
IPHYF
$1.50
$0.139.29%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 0.07% | -42.90% | 8.66% | -22.41% | -7.17% |
| Total Receivables | 0.07% | 531.54% | 8.66% | -23.50% | -7.18% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 0.07% | 10.87% | 8.65% | -20.37% | -7.17% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.07% | 50.37% | 8.66% | 227.32% | -7.17% |
| Total Current Assets | 0.07% | -28.18% | 8.66% | -20.88% | -7.17% |
|
|
|||||
| Total Current Assets | 0.07% | -28.18% | 8.66% | -20.88% | -7.17% |
| Net Property, Plant & Equipment | 0.07% | -12.17% | 8.65% | 0.78% | -7.18% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.07% | -90.51% | 8.66% | 32.98% | -7.18% |
| Total Assets | 0.07% | -32.58% | 8.66% | -12.64% | -7.17% |
|
|
|||||
| Total Accounts Payable | 0.07% | 64.10% | 8.66% | -40.03% | -7.17% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 0.07% | -1.57% | 8.66% | 7.10% | -7.17% |
| Total Finance Division Other Current Liabilities | 0.07% | 27.68% | 8.66% | 1.79% | -7.17% |
| Total Other Current Liabilities | 0.07% | 27.68% | 8.66% | 1.79% | -7.17% |
| Total Current Liabilities | 0.07% | 24.43% | 8.66% | -6.86% | -7.17% |
|
|
|||||
| Total Current Liabilities | 0.07% | 24.43% | 8.66% | -6.86% | -7.17% |
| Long-Term Debt | 0.07% | -23.87% | 8.66% | -15.55% | -7.17% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 0.09% | -35.82% | 8.64% | 51.53% | -7.16% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.07% | -15.65% | 8.66% | -10.46% | -7.17% |
| Total Liabilities | 0.07% | -3.93% | 8.66% | -10.34% | -7.17% |
|
|
|||||
| Common Stock & APIC | 0.07% | 0.16% | 8.66% | 8.75% | -7.17% |
| Retained Earnings | -0.07% | -6.73% | -8.66% | -10.17% | 7.17% |
| Treasury Stock & Other | 0.08% | -6.45% | 8.66% | 4,508.93% | -6.98% |
| Total Common Equity | -0.07% | -521.53% | 8.65% | -39.21% | -7.17% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -0.07% | -521.53% | 8.65% | -39.21% | -7.17% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -0.07% | -521.53% | 8.65% | -39.21% | -7.17% |
|
|
|||||